Editas Medicine (EDIT) Total Non-Current Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 10 years of Total Non-Current Liabilities data on file, last reported at $156.4 million in Q4 2025.

• Total Non-Current Liabilities for Q4 2025 came in at $156.4 million, down 23.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $156.4 million (down 23.41% YoY), and the FY2025 annual result was $156.4 million, down 23.41% from the prior year.
• Total Non-Current Liabilities fell to $156.4 million in Q4 2025 per EDIT's latest filing, from $183.6 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $204.2 million in Q4 2024 and troughed at $142.5 million in Q1 2024.
• A 4-year average of $166.8 million and a median of $155.0 million in 2022 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities soared 37.76% in 2024, then declined 23.41% in 2025.
• A 4-year view of Total Non-Current Liabilities shows it stood at $153.6 million in 2022, then fell by 3.5% to $148.3 million in 2023, then surged by 37.76% to $204.2 million in 2024, then slipped by 23.41% to $156.4 million in 2025.
• Business Quant data shows EDIT's Total Non-Current Liabilities at $156.4 million in Q4 2025, $183.6 million in Q3 2025, and $186.8 million in Q2 2025.